Building a Tolerance Platform to Promote Vascular Solid Organ Allograft Survival Using Three In Vivo Treatment Strategies: Post-Transplant Cyclophosphamide, Rapamycin, and Treg Expansion
Building a Tolerance Platform to Promote Vascular Solid Organ Allograft Survival Using Three In Vivo Treatment Strategies: Post-Transplant Cyclophosphamide, Rapamycin, and Treg Expansion
Creators
Brent J Pfeiffer
Henry Barreras Jr
Ashley Deboeuf
Robert B. Levy
Publication Details
Transplantation and cellular therapy, Vol.28(3), p.S354
Academic Unit
Miller School of Medicine; Microbiology and Immunology Research; UMMG Dept of Pediatrics - Critical Care; UMMG Department of Pediatrics